Evidence map›Paper›PMID 30364696›Full record

ArticleJournal of the Saudi Heart Association2019

Serum endostatin level as a marker for coronary artery calcification in type 2 diabetic patients.

Hazem M El-Ashmawy, Hisham S Roshdy, Zizi Saad, Azza M Ahmed

Open access · diamondAbstract read
In one paragraph

Article in Journal of the Saudi Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hazem M El-AshmawyDepartment of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig, EgyptEgypt.
Hisham S RoshdyDepartment of Cardiology, Faculty of Medicine, Zagazig University, Zagazig, EgyptEgypt.
Zizi SaadDepartment of Cardiology, Faculty of Medicine, Zagazig University, Zagazig, EgyptEgypt.
Azza M AhmedDepartment of Clinical Pathology, Faculty of Medicine, Zagazig University, Zagazig, EgyptEgypt.
Zagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the relationship between serum endostatin (ES) and coronary artery calcification (CAC) in type 2 diabetic (T2DM) patients.

methodsThe study included 110 participants with coronary artery disease (CAD); 55 with T2DM, for serum ES levels by enzyme-linked immunosorbent assay and CAC by contrast-enhanced spiral computed tomography (CT).

resultsMean serum ES value was 66.54 ng/mL [95% confidence interval (CI), 61.77-71.32 ng/mL]. Serum ES levels positively correlated with Agatston score index [ASI;

conclusionMeasurement of serum ES levels can improve diagnosis of CAC and could be useful as a high sensitive marker for the presence and progression of atherosclerosis in T2DM patients.

Indexed as

Coronary calcificationCoronary heart diseaseEndostatinType 2 DM

Identifiers

PMID30364696
PMCPMC6197639
OpenAlexW2891196682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.